{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:58:36Z","timestamp":1790776716034,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["ECTZ 64390"],"award-info":[{"award-number":["ECTZ 64390"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Major depressive episodes are highly prevalent among people living with HIV (PWH), despite sustained virological suppression. However, psychiatric outcomes among HIV controllers (HIC), who maintain long-term spontaneous control of viral replication without antiretroviral therapy (ART), remain poorly characterized. We assessed major depressive episodes and psychiatric symptom profiles among HIC compared with ART-treated PWH and explored associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective observational study, HIC from the French multicenter ANRS CO21 CODEX cohort were compared with PWH receiving suppressive ART. Major depressive episodes were assessed using the Mini-International Neuropsychiatric Interview (M.I.N.I.), and psychiatric symptoms were evaluated using the Symptom Checklist-90\u2013Revised. Between-group comparisons and univariable analyses were performed to identify factors associated with psychiatric outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety-eight participants were included (57 HIC and 41 ART-treated PWH). The prevalence of lifetime major depressive episodes was high in both groups and did not differ between HIC and ART-treated participants (35% vs 41%). Most psychiatric symptom dimensions were comparable between groups, although HIC showed higher interpersonal sensitivity and psychopathology composite scores on the SCL-90-R, reflecting higher psychological distress. In both groups, psychiatric outcomes were associated with preexisting psychiatric history, alcohol use, and sociodemographic factors, but not with immunovirological parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite spontaneous viral control, HIC do not exhibit more favorable psychiatric outcomes than ART-treated PWH. The high prevalence of depressive disorders appears to be primarily driven by behavioral and sociodemographic factors and preexisting psychiatric conditions rather than immunovirological status, supporting routine psychiatric assessment in HIV care, including for HIC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag513","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:21:52Z","timestamp":1790335312000},"source":"Crossref","is-referenced-by-count":0,"title":["Major Depressive Episodes and Psychiatric Symptoms Among HIV Controllers Compared With Antiretroviral-Treated People Living With HIV"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-2866","authenticated-orcid":false,"given":"Marion","family":"Camard","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, AP-HP, H\u00f4pital Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Hendou","sequence":"additional","affiliation":[{"name":"Center for Research in Epidemiology and Population Health (CESP), Universit\u00e9 Paris-Saclay, Inserm, INSERM U1018 , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bitu","sequence":"additional","affiliation":[{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelliah","family":"Mouanga","sequence":"additional","affiliation":[{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faroudy","family":"Boufassa","sequence":"additional","affiliation":[{"name":"Center for Research in Epidemiology and Population Health (CESP), Universit\u00e9 Paris-Saclay, Inserm, INSERM U1018 , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5222-8619","authenticated-orcid":false,"given":"Salome","family":"Laurans","sequence":"additional","affiliation":[{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Le Chenadec","sequence":"additional","affiliation":[{"name":"Center for Research in Epidemiology and Population Health (CESP), Universit\u00e9 Paris-Saclay, Inserm, INSERM U1018 , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Pla\u00e7ais","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, AP-HP, H\u00f4pital Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Avettand-Feno\u00ebl","sequence":"additional","affiliation":[{"name":"Virologie, CHU d\u2019Orl\u00e9ans , Orl\u00e9ans ,","place":["France"]},{"name":"Universit\u00e9 d\u2019Orl\u00e9ans, Facult\u00e9 de M\u00e9decine, LI2RSO, Orl\u00e9ans ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Meyer","sequence":"additional","affiliation":[{"name":"Center for Research in Epidemiology and Population Health (CESP), Universit\u00e9 Paris-Saclay, Inserm, INSERM U1018 , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"AP-HP, H\u00f4pital Bic\u00eatre, Service de Sant\u00e9 Publique, H\u00f4pital Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-6087","authenticated-orcid":false,"given":"Christine","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Corruble","sequence":"additional","affiliation":[{"name":"Mood Center Paris Saclay, 7AP-HP, H\u00f4pital Bic\u00eatre, Service Hospitalo-Universitaire de Psychiatrie de Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Center for Research in Epidemiology and Population Health (CESP), INSERM U1018, MOODS Team, Universit\u00e9 Paris-Saclay, Inserm , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, AP-HP, H\u00f4pital Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Colle","sequence":"additional","affiliation":[{"name":"Mood Center Paris Saclay, 7AP-HP, H\u00f4pital Bic\u00eatre, Service Hospitalo-Universitaire de Psychiatrie de Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Center for Research in Epidemiology and Population Health (CESP), INSERM U1018, MOODS Team, Universit\u00e9 Paris-Saclay, Inserm , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-617X","authenticated-orcid":false,"given":"Nicolas","family":"Noel","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, AP-HP, H\u00f4pital Bic\u00eatre , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Immune Diseases, Microbiology and Innovative Therapies (IDMIT\/UMRS1184), Universit\u00e9 Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses & Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"2026093009220486700_ofag513-B1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11904-021-00583-w","article-title":"Global systematic review of common mental health disorders in adults living with HIV","volume":"18","author":"Hoare","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026093009220486700_ofag513-B2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09540121.2023.2285733","article-title":"Global prevalence of depressive symptoms among people living with HIV\/AIDS: a systematic review and meta-analysis of the past five years","volume":"36","author":"Yang","year":"2024","journal-title":"AIDS Care"},{"key":"2026093009220486700_ofag513-B3","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1016\/S2352-3018(21)00319-2","article-title":"The risk of mental illness in people living with HIV in the UK: a propensity score-matched cohort study","volume":"9","author":"Gooden","year":"2022","journal-title":"Lancet HIV"},{"key":"2026093009220486700_ofag513-B4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1176\/appi.ajp.158.5.725","article-title":"Meta-analysis of the relationship between HIV infection and risk for depressive disorders","volume":"158","author":"Ciesla","year":"2001","journal-title":"Am J Psychiatry"},{"key":"2026093009220486700_ofag513-B5","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/s41380-022-01619-2","article-title":"Neuroinflammation in HIV-associated depression: evidence and future perspectives","volume":"27","author":"Mudra Rakshasa-Loots","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026093009220486700_ofag513-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-017-0239-3","article-title":"Association between major depressive disorder and pro-inflammatory cytokines and acute phase proteins among HIV-1 positive patients in Uganda","volume":"19","author":"Musinguzi","year":"2018","journal-title":"BMC Immunol"},{"key":"2026093009220486700_ofag513-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M14-0293","article-title":"Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data","volume":"161","author":"Mollan","year":"2014","journal-title":"Ann Intern Med"},{"key":"2026093009220486700_ofag513-B8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3851\/IMP3223","article-title":"Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999\u20132015","volume":"23","author":"Bengtson","year":"2018","journal-title":"Antivir Ther"},{"key":"2026093009220486700_ofag513-B9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10461-022-03916-x","article-title":"Mental health, ART adherence, and viral suppression among adolescents and adults living with HIV in South Africa: a cohort study","volume":"27","author":"Haas","year":"2023","journal-title":"AIDS Behav"},{"key":"2026093009220486700_ofag513-B10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/QAD.0000000000004200","article-title":"Food insecurity and mental health outcomes among people with HIV in West Africa","volume":"39","author":"Benzekri","year":"2025","journal-title":"AIDS"},{"key":"2026093009220486700_ofag513-B11","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1038\/s41598-022-10263-3","article-title":"A comprehensive analysis of excess depressive disorder in women and men living with HIV in France compared to the general population","volume":"12","author":"H\u00e9mar","year":"2022","journal-title":"Sci Rep"},{"key":"2026093009220486700_ofag513-B12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/433188","article-title":"HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication","volume":"41","author":"Lambotte","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026093009220486700_ofag513-B13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2007.08.010","article-title":"Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy","volume":"27","author":"Deeks","year":"2007","journal-title":"Immunity"},{"key":"2026093009220486700_ofag513-B14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx064","article-title":"A subset of extreme Human Immunodeficiency Virus (HIV) controllers is characterized by a small HIV blood reservoir and a weak T-cell activation level","volume":"4","author":"Canou\u00ef","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2026093009220486700_ofag513-B15","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25221","article-title":"Dynamics in HIV-DNA levels over time in HIV controllers","volume":"22","author":"Avettand-Fenoel","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"2026093009220486700_ofag513-B16","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100963","article-title":"Antiretroviral therapy for HIV controllers: reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort","volume":"37","author":"Pla\u00e7ais","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026093009220486700_ofag513-B17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/cid\/ciae440","article-title":"Risk of non-AIDS-defining events is lower in Antiretroviral Therapy (ART)-naive HIV controllers than in normal progressors on suppressive ART","volume":"80","author":"Groenendijk","year":"2025","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026093009220486700_ofag513-B18","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad067","article-title":"Non-AIDS-defining events in human immunodeficiency virus controllers versus antiretroviral therapy-controlled patients: a cohort collaboration from the French national agency for research on AIDS CO21 (CODEX) and CO06 (PRIMO) cohorts","volume":"10","author":"Manto","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026093009220486700_ofag513-B19","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.19.1.20524","article-title":"Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. military HIV natural history study","volume":"19","author":"Crowell","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"2026093009220486700_ofag513-B20","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/ciw120","article-title":"Analysis of non-AIDS-defining events in HIV controllers","volume":"62","author":"Dominguez-Molina","year":"2016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2026093009220486700_ofag513-B21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/infdis\/jiu809","article-title":"Hospitalization rates and reasons among HIV elite controllers and persons with medically controlled HIV infection","volume":"211","author":"Crowell","year":"2015","journal-title":"J Infect Dis"},{"key":"2026093009220486700_ofag513-B22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/1049732315617739","article-title":"Identity, representations, and beliefs: HIV controllers living on the frontier of good health and illness","volume":"26","author":"Pr\u00e9au","year":"2016","journal-title":"Qual Health Res"},{"key":"2026093009220486700_ofag513-B23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s10461-018-2237-8","article-title":"Does quality of life and sexual quality of life in HIV patients differ between non-treated HIV controllers and treated patients in the French ANRS VESPA 2 national survey?","volume":"23","author":"Pr\u00e9au","year":"2019","journal-title":"AIDS Behav"},{"key":"2026093009220486700_ofag513-B24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131922","article-title":"Immunologic and virologic progression in HIV controllers: the role of viral \u201cBlips\u201d and immune activation in the ANRS CO21 CODEX study","volume":"10","author":"Noel","year":"2015","journal-title":"PLoS One"},{"key":"2026093009220486700_ofag513-B25","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59 Suppl 20","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2026093009220486700_ofag513-B26","doi-asserted-by":"publisher","author":"Hergueta","DOI":"10.13140\/RG.2.1.2792.9440"},{"key":"2026093009220486700_ofag513-B27","first-page":"13","article-title":"SCL-90: an outpatient psychiatric rating scale\u2013preliminary report","volume":"9","author":"Derogatis","year":"1973","journal-title":"Psychopharmacol Bull"},{"key":"2026093009220486700_ofag513-B28","volume-title":"SCL-90-R: inventaire de sympt\u00f4mes psychologiques: manuel","author":"Derogatis","year":"2015"},{"key":"2026093009220486700_ofag513-B29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09540121.2022.2080802","article-title":"Prevalence of psychological distress among people living with HIV\/AIDS: a systematic review and meta-analysis","volume":"35","author":"Ma","year":"2023","journal-title":"AIDS Care"},{"key":"2026093009220486700_ofag513-B30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"2026093009220486700_ofag513-B31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01805-17","article-title":"Factors leading to the loss of natural elite control of HIV-1 infection","volume":"92","author":"Pernas","year":"2018","journal-title":"J Virol"},{"key":"2026093009220486700_ofag513-B32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181960","article-title":"Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: a systematic review and meta-analysis","volume":"12","author":"Bernard","year":"2017","journal-title":"PLoS One"},{"key":"2026093009220486700_ofag513-B33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11904-022-00600-6","article-title":"Metabolic consequences of antiretroviral therapy","volume":"19","author":"Diggins","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2026093009220486700_ofag513-B34","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s10461-014-0970-1","article-title":"Depression and apathy among people living with HIV: implications for treatment of HIV associated neurocognitive disorders","volume":"19","author":"Bryant","year":"2015","journal-title":"AIDS Behav"},{"key":"2026093009220486700_ofag513-B35","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1007\/s10461-021-03327-4","article-title":"Association of syndemic unhealthy alcohol use, smoking, and depressive symptoms on incident cardiovascular disease among veterans with and without HIV-infection","volume":"25","author":"Chichetto","year":"2021","journal-title":"AIDS Behav"},{"key":"2026093009220486700_ofag513-B36","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1007\/s10461-018-2164-8","article-title":"Food insecurity, internalized stigma, and depressive symptoms among women living with HIV in the United States","volume":"22","author":"Palar","year":"2018","journal-title":"AIDS Behav"},{"key":"2026093009220486700_ofag513-B37","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/QAD.0000000000002227","article-title":"Mental health and HIV\/AIDS: the need for an integrated response","volume":"33","author":"Remien","year":"2019","journal-title":"AIDS"},{"key":"2026093009220486700_ofag513-B38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0000000000000174","article-title":"Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients","volume":"28","author":"Noel","year":"2014","journal-title":"AIDS"},{"key":"2026093009220486700_ofag513-B39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbi.2020.09.012","article-title":"Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease","volume":"90","author":"Saloner","year":"2020","journal-title":"Brain Behav Immun"},{"key":"2026093009220486700_ofag513-B40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-023-02489-0","article-title":"Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms","volume":"13","author":"Mudra Rakshasa-Loots","year":"2023","journal-title":"Transl Psychiatry"},{"key":"2026093009220486700_ofag513-B41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAI.0000000000003063","article-title":"Higher soluble CD163 in blood is associated with significant depression symptoms in men with HIV","volume":"91","author":"Anderson","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026093009220486700_ofag513-B42","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae479","article-title":"Primary care guidance for providers who care for persons with human immunodeficiency virus: 2024 update by the HIV medicine association of the Infectious Diseases Society of America","author":"Horberg","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026093009220486700_ofag513-B43","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/hiv.13542","article-title":"Major revision version 12.0 of the European AIDS clinical society guidelines 2023","volume":"24","author":"Ambrosioni","year":"2023","journal-title":"HIV Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/10\/ofag513\/71519101\/ofag513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/10\/ofag513\/71519101\/ofag513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:22:15Z","timestamp":1790774535000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag513\/8853776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag513","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,29]]},"article-number":"ofag513"}}